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Potato aspartic proteases (StAPs) and their swaposin domain (StAsp-PSI) are proteins with cytotoxic activity
which involves plasma membrane destabilization. The ability of these proteins to produce cell death varies
with the cellular type. Therefore, StAPs and StAsp-PSI selective cytotoxicity could be attributed to the differ-
ent membrane lipid compositions of target cells. In this work we investigate the possible mechanism by
which StAPs and StAsp-PSI produce selective membrane destabilization. Results obtained from leakage assays
show that StAsp-PSI is a potent inducer of the leakage of LUVs containing anionic phospholipids, especially
those containing phosphatidylglycerol. Based in these results, we suggest that the cytotoxic activity of
StAsp-PSI on pathogenic microorganisms could be mediated by the attraction between the exposed positive
domains of StAsp-PSI and the negatively charged microorganism membrane. On the other hand, our circular
dichroism spectroscopic measurements and analysis by size exclusion chromatography and followed by elec-
trophoresis, indicate that hydrophobic environment is necessary to StAsp-PSI oligomerization and both
StAsp-PSI disulfide bounds and membrane with negative charged phospholipids are required by StAsp-PSI
to produce membrane destabilization and then induce cell death in tumors and microorganism cell targets.
Additionally, we demonstrate that the presence of cholesterol into the LUV membranes strongly diminishes
the capacity of StAsp-PSI to produce leakage. This result suggests that the lack of hemolytic and cytotoxic ac-
tivities on human lymphocytes of StAsp-PSI/StAPs may be partly due by the presence of cholesterol in these
cell membrane types.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
Aspartic proteases (EC 3.4.23) (AP) are a class of widely distributed
proteases present in animals, microbes, viruses and plants [1,2]. Biolog-
ical functions of plant APs have not yet been characterized to the extent
of their mammalian, microbial or viral counterparts [1–4]. Most of plant
AP sequences predict preproproteins, as in the case of animal and fungal
aspartic proteases, with a signal peptide and a proregion at the amino-
terminus of the mature protein [5]. However, plant AP genes have an
extra region of approximately 100 amino acids known as “plant specific
insert” (PSI) [3,4], similar to saposin-like proteins (SAPLIP) (Fig. 1A).
Structural analysis of PSI domains reveals a compact globular structure
formedby 5 alpha-helices linked to each other bydisulfide bridges [4,6].
PSI is not a true saposin domain; it is the swap of the N- and C-terminal
portions of the saposin like domain; hence, PSI is named as swaposin
domain [4] (Fig. 1B).
Saposin and saposin-like proteins and domains have diverse in vivo
biological functions or are implicated in different physiological func-
tions [7]. All these proteins bind to or interact with lipid membranes
and its “saposin-fold” is a common fold in a single globular struc-
ture [6–12] (Fig. 1C). Despite the conserved structural organization of
SAPLIPs, their distinct modes of interaction with biological membranes
are not fully understood. This could be the result of the differential in-
teractions with the biological membrane environments and/or differ-
ences in lipid cell membrane composition [12–16]. Several functions
have been proposed for PSI domain, as the targeting to the vacuole; ves-
icle leakage and a role in the processing of themature enzyme [4,14,17];
however, their role(s) in the plants is/are still speculative.
Previously, we have reported the cloned, heterologous expression
and purification of the PSI domain from a Solanum tuberosum aspartic
protease (StAsp-PSI) [6]. StAsp-PSI has high structural similarity with
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two saposin-like proteins with antimicrobial activity, NK-lysin and
granulysin [6,7]. Like these SAPLIPs, the StAsp-PSI domain is able to
interact with cell plasma membranes, increasing the cell permeability
and finally, producing cell death [6,18]. Additionally, in previous re-
ports we demonstrated that the cytotoxic activity of StAPs and
StAsp-PSI is selective. Whereas these proteins are toxic to plant and
human pathogen microorganisms and cancer cells, they are not able
to kill human T cells, human red blood cells and plant cells [6,18–23].
Like with a vast number of antimicrobial peptides from various sources,
StAPs and StAsp-PSI have been isolated and characterized; however, the
molecular explanation for their target specificity, or conversely, the rea-
son of the different susceptibilities of cells from different origins to
these proteins is not yet understood [6,18–24].
In order to search for the possible reasons of the differential cyto-
toxic activity of StAsp-PSI and StAPs, we have analyzed in this work
the ability of StAsp-PSI to induce membrane rupture of LUVs with dif-
ferent phospholipid compositions as well as changes in the StAsp-PSI
secondary structure and oligomerization capacity in membrane like
environments.
2. Materials and methods
2.1. Protein expression and purification
Recombinant StAsp-PSI was overexpressed in Escherichia coli M15
and purified as described previously [6]. Protein was stored in 50 mM
phosphate buffer, 25 mM NaCl, pH 7. Protein concentration was mea-
sured by the bicinchoninic acid method [25], using BSA as the standard.
2.2. Materials and reagents
Cholesterol (Chol), total bovine liver lipid extract (liver extract),
egg phosphatidic acid (EPA), egg L-α-phosphatidylcholine (EPC),
egg L-α-phosphatidylglycerol (EPG), and egg trans-esterified L-α-
phosphatidylethanolamine (TPE) were obtained from Avanti Polar
Lipids (Alabaster, AL, USA). Calcein, 5-Carboxyfluorescein (CF, N95%
by HPLC), dithiothreitol (DTT), 2,2,2-trifluoroethanol (TFE), Triton X-
100 and EDTA were purchased from Sigma-Aldrich (Madrid, ES). All
other chemicals were commercial samples of the highest purity avail-
able (Sigma-Aldrich, Madrid, ES). Water was deionized, twice-distilled
and passed through a Milli-Q equipment (Millipore Ibérica, Madrid,
ES) to a resistivity higher than 18 MΩ cm.
2.3. Vesicle preparation
Aliquots containing the appropriate amount of lipid in chloroform-
methanol (2:1 vol/vol) were placed in a test tube, the solvents were re-
moved by evaporation under stream of O2-free nitrogen, and finally,
traces of solvents were eliminated under vacuum in the dark forN3 h.
The lipid films were resuspended in an appropriate buffer and incubat-
ed either at 25 °C or 10 °C above the phase transition temperature (Tm)
with intermittent vortexing for 30 min to hydrate the samples and ob-
tainmultilamellar vesicles (MLV). The sampleswere frozen and thawed
five times to ensure complete homogenization and maximization of
protein/lipid contacts with occasional vortexing. Large unilamellar ves-
icles (LUV)with ameandiameter of 0.1 μmwere prepared fromMLVby
the extrusion method [26] using polycarbonate filters with a pore size
of 0.1 μm (Nucleopore Corp., Cambridge, CA, USA). Small unilamellar
vesicles (SUV) were prepared from MLVs using a Branson 250 sonifier
(40 W) equipped with a microtip until the suspension became
completely transparent. Every 30 s, the samples were cooled for 90 s
in ice to prevent overheating of the solution. The titanium particles
from the tip were removed by centrifugation at 15000 rpm at room
temperature for 15 min. For circular dichroism (CD) spectroscopy,
SUVs of different lipid compositionweremixedwith StAsp-PSI to a pro-
tein/lipid ratio 1:25. The phospholipid concentration was measured as
described previously [27].
Fig. 1. Sequence and structural homology between StAsp-PSI, CardoA-PSI and SAPLIPs. (A) Amino acid sequence alignment of the PSI domain of StAsp-PSI (GeneBank accession no.
AY672651) and CardoAPSI (GeneBank accession no. AJ132884) and permuted sequences of NK-lysin (GeneBank accession no. Q29075) and Granulysin (GeneBank accession no.
EAW99485). Sequences retrieved from databases were automatically aligned using CLUSTAL W algorithm. Conserved cysteines are highlighted in black, identical residues are
highlighted in gray and gaps are indicated by dashes. (B) The α-helical regions are indicated by boxes. The disordered part of the PSIs is marked by dotted line and gaps are indi-
cated by dashes. (C) Ribbon representation of the model structure of the PSI domain of StAsp-PSI and CardoAPSI based on the crystal structure of prophytepsin-PSI (PDB accession
no. 1QDM) and crystal structures of NK-lysin and Granulysin. Similar helixes are displayed in same color. The disordered part of the PSIs is marked by dotted line and disulfide
bridges by dashed lines. Similarities between StAsp-PSI, CardoAPSI, NK-lysin (PDB: 1NKL) and Granulysin (PDB: 1L9L) were determined using DeepView/Swiss-PdbViewer 3.7
program.
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2.4. Membrane leakage measurement
For assays of vesicle leakage at pH 7, LUVs with a mean diameter
of 0.1 μm were prepared as indicated above in buffer containing
10 mM Tris–HCl, 20 mM NaCl, 40 mM CF, and 0.1 mM EDTA, pH 7
[28], whereas for assays of vesicle leakage at pH 5.4, in buffer contain-
ing 20 mM citrate, 20 mM NaCl, and 40 mM calcein, pH 5.4 [29].
Breakdown of the vesicle membrane leads to content leakage, i.e.,
CF or calcein fluorescence. Nonencapsulated CF or calcein was sepa-
rated from the vesicle suspension through a Sephadex G-75 filtration
column (Pharmacia, Uppsala, Sweden) eluted with buffer containing
either 10 mM Tris–HCl, 100 mM NaCl, and 0.1 mM EDTA, pH 7, or
20 mM citrate, 100 mM NaCl, and 0.1 mM EDTA, pH 5.4. Leakage of
intraliposomal CF or calcein was assayed by treating the probe-loaded
liposomes (final lipid concentration, 0.125 mM) with the appropriate
amounts of StAsp-PSI on microtiter plates stabilized at 25 °C using a
microplate reader (FLUOstar, BMG Labtech, Germany), each well con-
taining a final volume of 170 μl. The medium in the microtiter plates
was continuously stirred to allow the rapid mixing of StAsp-PSI and
vesicles. One hundred percent release was achieved by adding Triton
X-100 to the microtiter plate to final concentration of 0.5% (w/w).
Changes in fluorescence intensity were recorded with excitation and
emission wavelengths set at 492 and 517 nm, respectively. Excitation
and emission slits were set at 5 nm. Leakage was quantified on a per-
centage basis as previously described [30,31].
2.5. Circular dichroism (CD) spectroscopy
Circular dichroism spectra were collected on a Jasco J810 spectro-
polarimeter fitted with a thermostated cell holder and interfaced
with a Neslab RTE-111 water bath. Spectral scans were performed
from 250 to 195 nm at 25 °C, with step resolution of 0.2 nm and band-
width of 2 nm. The counting rate was 50 nm/min with 2 s response
time. A 1 mm path length quartz cuvette was used for the measure-
ments, values from 10 scans were averaged per sample to improve
the signal-to-noise ratio and corrected for the contributions of vesi-
cles and buffer. Subtracted spectra were smoothed avoiding alter-
ation of spectral intensities. SUVs were used to obtain CD spectra.
No changes in turbidity (as measured at 445 nm) were observed
after StAsp-PSI addition to the SUV solutions. The results are
expressed as a mean of the residue ellipticity, [θ], using a value of
93.96 g/mol for the molecular weight of the mean residue. Secondary
structure fractions (α-helix, β-sheet and random coil) were deter-
mined by the use of the K2D2 web server accessible at http://www.
ogic.ca/projects/k2d2/ [32]. The estimated maximum error used for
the prediction analysis was 0.4.
2.6. Size exclusion chromatography
Oligomeric state of StAsp-PSI in the absence or presence of 15% TFE
was estimated by size exclusion chromatography on an equilibrated
Superdex 75 HR (10/30) column (Pharmacia, Uppsala, Sweden), con-
nected to a fast-protein liquid chromatography system, at a constant
flow rate of 1 ml/min at room temperature. The column was calibrated
using a mixture of four proteins of known molecular mass, i.e. ovalbu-
min (44.3 kDa), glyceraldehyde-3P-dehydrogenase (36 kDa), lysozyme
(14.3 kDa), and insulin (6 kDa). The column was equilibrated with
50 mM phosphate buffer, 25 mM NaCl, pH 7, with or without 15% TFE.
Samples with TFE were incubated for 2 h at 37 °C before load into the
column. Fractions of 1 mlwere collected and the elutionwasmonitored
at 280 nm.
2.7. Gel electrophoresis
The complex formation of StAsp-PSI in presence of 15% TFE was
investigated by NATIVE-PAGE analysis using 15% (w/v) acrylamide
gel, according to [33] and a running buffer containing 96 mM glycine
and 12.5 mM Tris, pH 8.8. Samples with TFE were incubated for 2 h at
37 °C before NATIVE-PAGE was made. Gels were stained with silver
nitrate as described previously [34].
3. Results
3.1. StAsp-PSI permeabilizes negatively charged membranes
In order to analyze the interaction of StAsp-PSI with phospholipid
membranes, artificial vesicles consisting of lipids only were used. We
tested the ability of StAsp-PSI to rupture membrane vesicles by mon-
itoring the release of fluorescent probes trapped inside the liposomes.
We evaluated also the effect of the different phospholipid composi-
tion on the capability of StAsp-PSI to interact with membranes. The dif-
ferent phospholipids used in this work were the negatively charged
lipids EPG and EPA and the zwitterionic lipids EPC and TPE. Vesicles
containing cholesterol and lipids from a liver extract were used to
study the effect of StAsp-PSI on membranes resembling mammalian
plasma membranes.
Fig. 2 shows the capability of StAsp-PSI to induce CF release from
preloaded LUVs. Furthermore, the extent of release was dependent
on the LUV phospholipid composition. The results obtained show
that StAsp-PSI was able to produce vesicle leakage and the release
of vesicle content of LUVs containing negative phospholipids in a
dose-dependent manner (Fig. 2). In contrast, StAsp-PSI was unable
to permeabilize LUVs composed of zwitterionic phospholipids (EPC
and TPE) or a liver lipid extract, at the different times and StAsp-PSI
concentrations assayed. In LUVs containing EPC/EPA and EPC/EPG at
molar ratios of 5:4, 50% of the vesicle contents were released at
3.5 μM and 2.25 μM of StAsp-PSI, respectively. The importance of the
disulfide bonds in the capability of StAsp-PSI to permeabilize LUVs
was clearly observed when this protein was preincubated with DTT.
As it can be observed in Fig. 2, reduced StAsp-PSI was not able to in-
duce the CF release from vesicles at any times, protein amounts and
LUV compositions assayed.
The leakage of LUVs induced by StAsp-PSI was found to be pH-
dependent (Fig. 3). In EPC/EPG containing vesicles, the initial rate
and the maximal percentage of the fluorescence release induced by
StAsp-PSI were dose-dependent at pH 7 (Fig. 3A). The highest per-
centage of CF release was observed at 8.3 μM StAsp-PSI (about 85%)
at pH 7, whereas at pH 5.4 only 50% of the trapped calcein was re-
leased with this StAsp-PSI concentration.
Fig. 2. Effect of StAsp-PSI on the release of LUV contents for different lipid compositions
at pH 7 and 45 min of incubation. The lipid compositions used were EPC (○), EPC/TPE
at a molar ratio of 5:2 (▼), EPC/EPG at a molar ratio of 5:4 (●), EPC/EPA at a molar ratio
5:4 (□), EPC/Chol at a molar ratio 5:2 (■), liver extract (Δ), EPC/EPG at a molar ratio
5:4 in the presence of 0.2 mM DTT (▲), and EPC/EPA at a molar ratio of 5:4 in the pres-
ence of 0.2 mM DTT ( ). Error bars indicate standard deviations of the mean of triplicate
samples.
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3.2. Cholesterol affects the StAsp-PSI leakage activity
We tested the ability of StAsp-PSI to produce leakage on vesicles
with eukaryote membrane like composition (liver extract-containing
vesicles and cholesterol-containing vesicles). Fig. 2 shows that StAsp-
PSI was unable to permeabilize membranes of LUVs containing the
complex liver lipids mixture at all StAsp-PSI concentration and times
assayed.
Results observed in Fig. 4 show that the presence of cholesterol re-
duces the CF release produced by StAsp-PSI in both EPC/EPA and
EPC/EPG containing vesicles. In EPC/EPA/Chol containing vesicles
the cholesterol effect is dose-dependent at all StAsp-PSI amounts
assayed (Fig. 4A). However, in EPC/EPG/Chol containing vesicles this
effect was more evident and stronger; at a lipid molar ratio 5:4:1,
the leakage produced by StAsp-PSI diminishes in a 90% approximately
(Fig. 4B).
3.3. Secondary structure of StAsp-PSI
The far-UV CD spectra (195–250 nm) of StAsp-PSI domain in
50 mM phosphate buffer pH 7 at 25 °C shows two strong ellipticity
values around 208 and 222 nm that indicate the presence of helical
conformations (Fig. 5). Analysis of the solution CD spectra of StAsp-
PSI using the K2D2 method [32] also suggested that the protein had
a dominant helical conformation (54%) (Table 1) with lesser contri-
butions from β-sheet components (6%) and random structures (40%).
In order to evaluate the effect of lipid membrane composition on the
StAsp-PSI secondary structure we determined whether its CD spectrum
changed in presence of SUVs containing zwitterionic lipids (EPC); zwit-
terionic and negative lipids (EPC/EPA; EPC/EPG) (Fig. 5A). Data showed
in Table 1 demonstrate that, in SUVs containing EPC, a decrease of StAsp-
PSIα-helix content fromwas observed (from 54% to 48%). When StAsp-
PSI was incubated with SUVs containing negatively charged phospho-
lipids, a significant decrease in the α-helix content was observed, from
54% to 32% and 27% for SUVs containing EPC/EPA and EPC/EPG at
molar ratios of 5:2, respectively. No significant changes were observed
in the StAsp-PSI secondary structure in the presence of DTT (Fig. 5B).
The ratio of the ellipticities at 222 and 208 nm can be utilized to dis-
tinguish between monomeric and oligomeric states of helices [35];
when the ratio θ222/θ208 is about 0.8, the peptide is in its monomeric
state, and when the ratio exceeds the value of 1.0 is in the oligomeric
state. Results obtained show that in presence of SUVs containing EPC
the StAsp-PSI ratio θ222/θ208 is 0.8, suggesting that StAsp-PSI is mainly
in the monomeric state. In the presence of SUVs containing EPC/EPA
and EPC/EPG at molar ratios of 5:2, the StAsp-PSI θ222/θ208 ratios were
approximately 1.9 and 1.5 respectively. These values suggest that in
the presence of SUVs containing negatively-charged phospholipids,
StAsp-PSI is mostly in oligomeric state.
To study the tendency of StAsp-PSI to oligomerize we performed size
exclusion chromatography in presence of trifluoroethanol (TFE) as de-
scribed in the materials andmethods section. TFE is one of the most fre-
quently used membrane-mimetic organic co-solvents to determine the
Fig. 3. Effect of StAsp-PSI on the release of LUV contents frommembranes composed of EPC/EPG at a molar ratio of 5:4 at pH 7 (A) and pH 5.4 (B). The StAsp-PSI concentrations used
were 0 μM (◊), 1.25 μM (■), 2.48 μM (□), 5 μM (●), and 8.26 μM (○). Error bars indicate standard deviations of the mean of triplicate samples.
Fig. 4. Effect of Chol on StAsp-PSI-induced release of LUV contents on negatively charged membranes containing either EPA (A) or EPG (B) at pH 7 and 45 min of incubation. Lipid
compositions containing EPA (A) were EPC/EPA at a molar ratio of 5:4 (♦), EPC/EPA/Chol at a molar ratio of 5:4:1 (■), EPC/EPA/Chol at a molar ratio of 5:4:2 (□), EPC/EPA/Chol at a
molar ratio of 5:4:3 (●), and EPC/EPA/Chol at a molar ratio of 5:4:4 (○). Lipid compositions containing EPG (B) were EPC/EPG at a molar ratio of 5:4 (♦), EPC/EPG/Chol at a molar
ratio of 5:4:1 (■), EPC/EPG/Chol at a molar ratio of 5:4:2 (□), EPC/EPG/Chol at a molar ratio of 5:4:3 (●), and EPC/EPG/Chol at a molar ratio of 5:4:4 (○). Error bars indicate standard
deviations of the mean of triplicate samples.
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induced conformation relevant to peptide antimicrobial activity [36,37].
When proteins or peptides are transferred fromwater tomembrane like
interfaces, a decrease in the proteins or peptides environmental polarity
occurs. The data obtained show that no significant changes were
detected in the StAsp-PSI α-helix content in the presence of 15% and
20% TFE (Fig. 5B, Table 1). At 15% TFE, StAsp-PSI adopts anα-helical con-
formation with the monomer/oligomer equilibrium shifted toward the
oligomeric state with a ratio θ222/θ208 of approximately 1.2, and at 20%
TFE the ratio increases to 1.8, showing that the predominant state is
the oligomeric one.
StAsp-PSI was chromatographed in a size exclusion chromatogra-
phy under hydrophilic and hydrophobic conditions in order to deter-
mine, by an experimental procedure, the transition of StAsp-PSI from
the monomeric state to the oligomeric state. The chromatographic pro-
file obtained under hydrophilic conditions shows a unique peak; corre-
sponding to a molecular weight of 10 kDa, approximately (Fig. 6A). In
the presence of 15% TFE, three peaks were determined in the column
elution profile, corresponding to molecular weights of 10 kDa and
22 kDa, approximately, and another peak corresponding to a molecular
weight greater than 100 kDa. The band pattern of the size exclusion
chromatography pools analyzed by NATIVE-PAGE shows a unique
band and three bands in hydrophilic and hydrophobic conditions re-
spectively (Fig. 6B, lanes 1 and 2). These results are in agreement with
the results predicted from the CD data, and support the fact that the
StAsp-PSI domain is present in a monomeric form under hydrophilic
conditions; however, StAsp-PSI has a tendency to form dimers and/or
higher order oligomers in a hydrophobic environment.
Additionally, the importance of the intermolecular disulfide bonds
in the StAsp-PSI oligomerization was demonstrated when, a decrease
in the amount of the dimeric form and an increase in the amount of
the monomeric form were observed in presence of 15% TFE and DTT
(Fig. 6A and B, lane 3).
Fig. 5. CD spectra of StAsp-PSI in solution, bound to SUVs containing different phospholipidic compositions (A) and in the presence of different TFE concentrations or 0.2 mM DTT
(B), at pH 7 and 25 ºC. Protein concentration was 50 μM for all the samples, and the lipid/protein ratio was 25:1. [θ]mrw, mean of the residue ellipticity.
Table 1
Estimation of the secondary structure content of StAsp-PSI in solution with or without
DTT, TFE, and bound to SUVs of different phospholipidic composition at pH 7 and 25 °C,
as determined by circular dichroism using the K2D2 algorithm. Conformation values





StAsp-PSI 54 6 40 0.8 Monomeric
StAsp-PSI+0.2 mM DTT 51 8 41 0.9 Monomeric
StAsp-PSI+15% TFE 52 9 39 1.2 Oligomeric
StAsp-PSI+20% TFE 55 8 36 1.8 Oligomeric
StAsp-PSI+EPC 48 8 44 0.8 Monomeric
StAsp-PSI+EPC/EPA (5:2) 31 14 55 1.9 Oligomeric
StAsp-PSI+EPC/EPG (5:2) 27 18 55 1.5 Oligomeric
Fig. 6. Oligomeric state of StAsp-PSI. (A) The upper panel shows the calibration curve as
well as the elution times of StAsp-PSI in the absence or presence of 15% TFE. Elution
times of proteins used for calibration are indicated by solid squares, and elution
times of StAsp-PSI under the different conditions are indicated according to the differ-
ent oligomeric state (monomeric StAsp-PSI without TFE (●), monomeric StAsp-PSI in
TFE (○), dimeric StAsp-PSI in TFE (□), high MW StAsp-PSI in TFE (Δ). The lower
panel contains the elution profiles of StAsp-PSI from Superdex 75 HR 10/30 column. Ex-
periments were performed at pH 7 in the absence (dashed-dotted line), in the presence
of 15% TFE (dotted line) or in the presence of 15% TFE, previously treated with 1 mM
DTT for 3 h at 37 ºC (solid line). The protein elutes as a monomer in the absence of
TFE, and predominantly as a monomer and dimer in the presence of TFE. Absorption
(arbitrary units, AU) was measured at 280 nm. (B) NATIVE-PAGE analysis of the molec-
ular organization of StAsp-PSI in the absence (lane 1), in the presence of TFE (lane 2) or
previously treated with 1 mM DTT for 3 h at 37 ºC in the presence of TFE (lane 3). Gel
was silver stained.
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4. Discussion
We have previously reported that StAPs and StAsp-PSI have cyto-
toxic activity, that this activity involves plasma membrane destabili-
zation and that the ability of these proteins to produce cell death is
dependent of the cellular type [6,18,21]. The results herein presented
contribute to understand the possible selective mechanism underly-
ing the cytotoxic activity of StAPs and StAsp-PSI.
Results obtained here show that StAsp-PSI is a potent inducer of
the leakage of LUVs containing anionic phospholipids. In agreement
with the results reported for other α-helix antimicrobial peptides,
StAsp-PSI shows a remarkable preference for phosphatidylglycerol
and the inability to permeabilize LUVs containing only zwitterionic
phospholipids [24]. As described for these peptides, the preference
of StAsp-PSI to interact with LUVs with negative charge may be
explained by the electrostatic interactions produced between the
positives exposed protein domains and the negative charge of LUVs
[38–40]. Natural cell membranes are complex entities consisting of
a variety of components. Eukaryotic and prokaryotic cell membranes
differ in their physical and chemical properties. Specifically, prokary-
otic cell membranes contain higher amounts of anionic phospholipids
than eukaryotic cell membranes, but do not contain sphingomyelin
and cholesterol [41–46]. Therefore, the interaction of StAsp-PSI with
plant and human pathogenic microorganisms and the subsequent
pathogen cell death could be explained as the attraction between
the exposed positive domains of StAsp-PSI and the negatively charged
microorganism membrane.
Several reports relate the hemolytic activity of antimicrobial pep-
tides with the capacity of these peptides to strongly interact with either
membranes, containing cholesterol or not [47,48]. Like in the case of an-
timicrobial peptides unable to lyse red blood cells [49], the presence of
cholesterol into the LUVmembranes strongly diminishes the capacity of
StAsp-PSI to produce leakage, in a dose-dependent manner and at all
StAsp-PSI concentration assayed. Cholesterol presence in the mem-
branes causes a reduction of the density of the hydrophobic head
group at the interfacial region of the bilayer and an increase in the pack-
aging of the phospholipid tails in the middle of the bilayer [50]. There-
fore, the high rate of hydration of lipid head group at the interface
bilayer region found in cholesterol-richmembranes is probably respon-
sible to reduce the StAsp-PSI–LUV interaction. As reported before for
other antimicrobial peptides [48], we suggest that the loss detected in
the StAsp-PSI leakage capacity may be a consequence of a non relevant
StAsp-PSI insertion into the bilayer and probably only a transient bind-
ing occurs that do not significantly affect the stability of themembranes
of cholesterol containing LUVs. This suggestion is supported by previous
results that show that StAsp-PSI/StAPs are able to bind to human red
blood cells, but do not produce plasma cell membrane destabilization
and therefore cell death [6,18]. Thus, the lack of hemolytic and cytotoxic
activities on human lymphocytes of StAsp-PSI/StAPs may be partly due
by the presence of cholesterol in these cell membrane types. Future as-
says using calorimetry, infrared and NMR should be performed to cor-
roborate this hypothesis.
On the other hand, we have attempted to analyze the possible
structural changes in StAsp-PSI induced by interaction with mem-
branes differing in lipid composition. Analysis of CD data indicates
that, in the presence of lipid vesicles containing negatively charged
phospholipids, StAsp-PSI undergoes significant changes in its second-
ary structure. These changes consist in a decrease in the α-helix con-
tent and an increase in the percentage of random coil. Contrary to
this, in the presence of vesicles containing only zwitterionic phospho-
lipids or in the presence of TFE a non-significant change in the StAsp-
PSI overall structure was observed. Additionally, analysis by size ex-
clusion chromatography and electrophoresis showed that StAsp-PSI
is a monomer in a hydrophilic environment, whereas in a hydropho-
bic one monomeric, dimmeric and aggregated forms are found. These
results are consistent with the scheme proposed by Khandelia et al.,
(2008) [51] where, the secondary structure induced in different pep-
tides ultimately determines their selectivity profile. Hence for StAsp-
PSI, as well as for other AMPs [52–54], the membrane has as strong
influence on peptide conformation as the peptide has on membrane
integrity.
We have previously reported the importance of disulfide bonds in
StAsp-PSI antitumor and antimicrobial activity [6,21]. Here, we demon-
strate that the reduction of disulfide bonds does not induce significant
changes in the StAsp-PSI secondary structure. However, as a conse-
quence of disulfide bonds reduction StAsp-PSI loses its vesicle leakage
capacity, and there is a transition to the monomeric StAsp-PSI state
from the StAsp-PSI dimeric and oligomeric states. These data and the
prediction analysis of CD assays suggest that the aggregation of StAsp-
PSI is necessary for peptide induced vesicle leakage and cytotoxic activ-
ity on tumor and microorganism cells, like in other SAPLIPs [6,18,21].
Therefore, a hydrophobic environment is necessary to produce StAsp-
PSI oligomerization and both, StAsp-PSI disulfide bonds and membrane
with negatively-charged phospholipids, are required by StAsp-PSI to
produce membrane destabilization and then induce cell death in tu-
mors and microorganism cell targets.
Finally, and in order to correlate the results herein shown with the
possible biological role of StAsp-PSI/StAPs in the plant defense response,
we have focused our attention to three facts. In the first place, the
changes in phospholipid plasma membrane composition in plant cells
under stress conditions. Several reports reveal the existence of two
major phospholipid components: phosphatidylcholine and phosphati-
dylethanolamine; and minor components as, phosphatidylinositol,
phosphatidylserine and phosphatidylglicerol into the plasma cell mem-
branes of a great number of plant species [55,56]. On the other hand,
changes in the plasma membrane phospholipids content have been
reported when plants are exposed to stress conditions. In Arabidopsis
thaliana, the content of phosphatidic acid increases while a decrease
of the content of phosphatidylcholine and phosphatidylethanolamine
was observed. The authors suggest that, the loss in phosphatidylcholine
and the increase in phosphatidic acid content may be responsible of
destabilizing membrane bilayer structure, resulting in cell death [56].
In the second place, the preference of StAsp-PSI to permeabilize LUVs
containing phosphatidic acid, i.e., with a negative net charge, has been
described above. Thirdly, the presence of the PSI domain in the amino
acid sequences of plant AP precursors or mature proteins, including
StAPs; and the localization of these proteins in tissues undergoing pro-
grammed cell death (PCD) [22,23,57–59]. PSI functions in plant APs
are still unclear; however, several roles have been suggested in the
plant PCD [10,14,60–62]. Specifically, the presence of this domain
into the mature AP proteins from potato (StAPs); tomato (LycoAP)
[63] and Nepenthes alata (NaAP4) [64], has been considered as
being a part of the defensivemachinery against pathogens and/or an ef-
fector of cell death [14,18,64]. Therefore, this background, togetherwith
the results obtained here, allow us to suggest that destabilization of
plasma membrane of stressed cells may be a consequence of changes
in the chemical and physical properties of the plasma cell membranes
and/or proteins that, like StAsp-PSI, are able to permeabilize mem-
branes containing mainly negative phospholipids. All these events, to-
gether or separately, cause the subsequent cell death. On the basis of
the antecedents and results described above, we propose that, the pos-
sible role of StAPs as pathogenesis related proteins into the plant defen-
sive response is to interact with the pathogen plasma membrane
causing membrane destabilization and subsequently pathogen cell
death and/or kill plant cells under stress conditions, contributing to cir-
cumscribe pathogen spread and colonization.
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